openPR Logo
Press release

Electrophysiology Ablation Market is Expected to Reach a Valuation of US$ 8,765.6 Million by 2034 | Fact.MR Report

05-15-2024 08:51 AM CET | Health & Medicine

Press release from: Fact.MR

Electrophysiology Ablation Market

Electrophysiology Ablation Market

The global electrophysiological ablation market was valued at $3,702.6 million in 2024 and is expected to grow at a 9.0% CAGR through 2034. The electrophysiological ablation market is expected to exceed $8,765.6 million by 2034.

The market is being shaped by an increased emphasis on radiation protection and safety considerations during electrophysiological ablation procedures. Businesses who proactively incorporate safety measures into their goods stand to gain a competitive edge, comply with evolving legislation, and meet the growing demand to protect the health of patients and healthcare providers.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9379

Understanding the genetic and molecular roots of arrhythmias is leading the industry toward a more personalized treatment strategy. Businesses who are at the forefront of incorporating genetic insights and risk categorization approaches into their products are developing a unique value proposition that addresses the growing demand for tailored treatment plans and patient-centered healthcare solutions.

Outpatient electrophysiology facilities are intentionally being built to meet the growing demand for accessible and effective healthcare delivery. Businesses that make strategic investments in specialized facilities for elective ablation procedures outside of traditional hospital settings are well positioned to earn market share in the rapidly growing outpatient care industry. This trend supports changing patient preferences while providing opportunity to improve operational workflows and maximize resource utilization, hence increasing market expansion and profitability.

"Success in the competitive market for electrophysiological ablation is dependent on patient-centered innovation, strategic flexibility, and good regulatory navigation. To effectively navigate market volatility, sector executives value proactive activities, regulatory awareness, and adaptable strategies. Resilient firms prioritize strategic alliances, innovation, and a comprehensive approach to patient care to ensure long-term success in cardiovascular medicines." Says a Fact.MR analyst.

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.factmr.com/report/electrophysiology-ablation-market

Key Companies Profiled in This Report

Medtronic
Abbott Laboratories
Boston Scientific Corporation
Johnson & Johnson (Biosense Webster)
Siemens Healthineers
St. Jude Medical (now part of Abbott)
Biotronik
Stereotaxis
AtriCure
MicroPort Scientific Corporation

Key Takeaways from the Electrophysiology Ablation Market Report

The global electrophysiological ablation market was valued at US$ 2,634.9 million in 2019.
By 2024, North America's electrophysiology ablation market will account for 33.0% of the global market.
By 2024, Latin America will account for 7.6% of the worldwide electrophysiological ablation market.
The ablation catheter segment is anticipated to account for 46.8% of the market in 2024.
The hospital sector is expected to account for 58.3% of the market share in 2024.
The market in the United States is expected to grow at an 8.2% CAGR till 2034.
The Brazilian market is expected to grow at an 8.6% CAGR through 2034.

Competitive Landscape

The electrophysiological ablation industry is highly competitive, with major players such as Medtronic and Abbott Laboratories vying for supremacy. Mergers, acquisitions, and partnerships are some of the techniques utilized to expand portfolios and global reach.

Technological leadership is essential, with a focus on innovative solutions and the incorporation of artificial intelligence and advanced mapping technology. Timely regulatory clearances, excellent marketing, wide service offerings, and training programs all contribute to market leadership. Adapting to changes in healthcare policy and being current on market developments are essential for remaining competitive in this turbulent environment.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9379

Recent Developments

Medtronic plc, a renowned worldwide medical technology supplier, announced in December 2023 that the PulseSelect Pulsed Field Ablation (PFA) System has been approved by the FDA for the treatment of paroxysmal and persistent atrial fibrillation. Following the PulseSelect PFA system's November European CE (Conformité Européenne) Mark, this is the FDA's first PFA technology approval.

Abbott announced in May 2023 that the FDA has authorized the TactiFlex Ablation Catheter, Sensor EnabledTM, the world's first ablation catheter featuring a flexible tip and contact force technology.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Electrophysiology Ablation Market is Expected to Reach a Valuation of US$ 8,765.6 Million by 2034 | Fact.MR Report here

News-ID: 3496913 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Ablation

Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
03-12-2021 | Health & Medicine
Fact.MR
Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgic …
Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces
01-21-2021 | Health & Medicine
Fact.MR
Cardiac Ablation Technologies Market
Growing acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market. However, an extensive study published by Fact.MR raises concerns regarding technical complexity leading to lack of required operational competency, which leads to fundamental barriers to the adoption of advanced ablation systems. Request
Radiofrequency Ablation Devices Market: Emerging Applications of Radiofrequency …
Radiofrequency ablation is a minimally invasive technique that uses heat and electrical energy to destroy cancer cells and other dysfunctional tissues. Recently, it has been used to treat a wide range of medical conditions. Although it is not a primary treatment of cancer, it is used to treat a spot of tumor causing pain and other medical indications. The technique is also used to treat patients suffering from adrenal gland,
Nerve Ablation Devices Market to Record an Exponential CAGR by 2028(Based on pro …
Nerves are the vital part of the body, responsible for carrying signals from different parts of the body to the brain. The nerves carry electrical signals that act on actions such as pain and other movements of the body. The nerve ablation devices are used to treat patient by minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. The nerve ablation devices help
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat